|Articles|February 1, 1997

Looking Beyond the Formulary Budget: Cost Analysis and a Psychiatric Perspective
Volume 3
Issue 2 Suppl

Retrospective Analysis of the Effect of Risperidone on Clinical Outcome

Author(s)Daniel C. Javitt, MD, PhD, Arnaldo Negron, MD, Liviu Sigler, MD

Download PDF: Retrospective Analysis of the Effect of Risperidone on Clinical Outcome

Articles in this issue

over 29 years ago

Article

Introduction: Looking Beyond the Formulary Budget

over 29 years ago

Article

Evaluating the Cost Effectiveness of Newer Psychotropic Medications

over 29 years ago

Article

Looking Beyond the Formulary Budget in Cost-Benefit Analysis

over 29 years ago

Article

Newer Antipsychotic Medications: Discussions

over 29 years ago

Article

Bibliography

over 29 years ago

Article

Participants

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Retrospective Analysis of the Effect of Risperidone on Clinical Outcome

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

Avoiding TNF Cycling: When to Switch Drug Classes in Rheumatoid Arthritis

Predicting GLP-1 Discontinuation From Pharmacy Claims

Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups

Full Data Published Showing 87% CR at 3 Years for Epcoritamab Plus BR in First-Line FL

A Look at PBM Reform and Transparency: Payer, Provider and Patient Impact

Retrospective Analysis of the Effect of Risperidone on Clinical Outcome

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

Avoiding TNF Cycling: When to Switch Drug Classes in Rheumatoid Arthritis

Predicting GLP-1 Discontinuation From Pharmacy Claims

Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups

Full Data Published Showing 87% CR at 3 Years for Epcoritamab Plus BR in First-Line FL